APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Sotalol

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Sotalol Industry Growth and Trends Forecast to 2032

Report ID 174037090120 December 202595 pages

Choose your research edition.

Industry ResearchSotalol Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Sotalol Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Sotalol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sotalol Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Sotalol Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Sotalol market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sotalol is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sotalol is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sotalol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sotalol include Shaanxi Hanjiang Pharmaceutical Group, GSK, Bayer, Samarth Pharma Pvt. Ltd., Cipla Limited, Cambrex, Bristol-Myers Squibb (BMS), Arevipharma and Arbor Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sotalol market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sotalol market size, estimates, and forecasts are presented in terms of sales volume (m units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sotalol market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sotalol.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Sotalol market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sotalol Market by Company

Shaanxi Hanjiang Pharmaceutical Group

GSK

Bayer

Samarth Pharma Pvt. Ltd.

Cipla Limited

Cambrex

Bristol-Myers Squibb (BMS)

Arevipharma

Arbor Pharmaceuticals

Sotalol Segment by Type

40mg Sotalol

80mg Sotalol

Sotalol Segment by Application

Sustained Ventricular Tachycardia

Atrial Fibrillation/Flutter

Sotalol Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sotalol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sotalol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sotalol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sotalol manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Sotalol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 40mg Sotalol Table 2. Major Company of 80mg Sotalol Table 3. Global Sotalol Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Sotalol Sales by Type (2021-2026) & (m units) Table 5. Global Sotalol Sales Market Share in Volume by Type (2021-2026) Table 6. Global Sotalol Sales by Type (2021-2026) & (US$ Million) Table 7. Global Sotalol Sales Market Share in Value by Type (2021-2026) Table 8. Global Sotalol Price by Type (2021-2026) & (US$/k unit) Table 9. Global Sotalol Sales by Type (2027-2032) & (m units) Table 10. Global Sotalol Sales Market Share in Volume by Type (2027-2032) Table 11. Global Sotalol Sales by Type (2027-2032) & (US$ Million) Table 12. Global Sotalol Sales Market Share in Value by Type (2027-2032) Table 13. Global Sotalol Price by Type (2027-2032) & (US$/k unit) Table 14. North America Sotalol Sales by Type (2021-2026) & (m units) Table 15. North America Sotalol Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Sotalol Sales by Type (2021-2026) & (m units) Table 17. Europe Sotalol Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Sotalol Sales by Type (2021-2026) & (m units) Table 19. Asia-Pacific Sotalol Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Sotalol Sales by Type (2021-2026) & (m units) Table 21. Latin America Sotalol Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Sotalol Sales by Type (2021-2026) & (m units) Table 23. Middle East and Africa Sotalol Sales by Type (2021-2026) & (US$ Million) Table 24. Sotalol Industry Trends Table 25. Sotalol Industry Drivers Table 26. Sotalol Industry Opportunities and Challenges Table 27. Sotalol Industry Restraints Table 28. Global Sotalol Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Sotalol Revenue Market Share by Company (2021-2026) Table 30. Global Sotalol Sales by Company (2021-2026) & (m units) Table 31. Global Sotalol Sales Share by Company (2021-2026) Table 32. Global Sotalol Market Price by Company (2021-2026) & (US$/k unit) Table 33. Global Sotalol Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Sotalol Major Company Production Sites and Headquarters Table 35. Global Sotalol Company, Product Type & Application Table 36. Global Sotalol Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Sotalol by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Sotalol Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Sotalol Sales by Region (2021-2026) & (m units) Table 41. Global Sotalol Sales Market Share in Volume by Region (2021-2026) Table 42. Global Sotalol Sales by Region (2021-2026) & (US$ Million) Table 43. Global Sotalol Sales Market Share in Value by Region (2021-2026) Table 44. Global Sotalol Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 45. Global Sotalol Sales by Region (2027-2032) & (m units) Table 46. Global Sotalol Sales Market Share in Volume by Region (2027-2032) Table 47. Global Sotalol Sales by Region (2027-2032) & (US$ Million) Table 48. Global Sotalol Sales Market Share in Value by Region (2027-2032) Table 49. Global Sotalol Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2027-2032) Table 50. Global Sotalol Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Sotalol Sales by Application (2021-2026) & (m units) Table 52. Global Sotalol Sales Market Share in Volume by Application (2021-2026) Table 53. Global Sotalol Sales by Application (2021-2026) & (US$ Million) Table 54. Global Sotalol Sales Market Share in Value by Application (2021-2026) Table 55. Global Sotalol Price by Application (2021-2026) & (US$/k unit) Table 56. Global Sotalol Sales by Application (2027-2032) & (m units) Table 57. Global Sotalol Sales Market Share in Volume by Application (2027-2032) Table 58. Global Sotalol Sales by Application (2027-2032) & (US$ Million) Table 59. Global Sotalol Sales Market Share in Value by Application (2027-2032) Table 60. Global Sotalol Price by Application (2027-2032) & (US$/k unit) Table 61. North America Sotalol Sales by Application (2021-2026) & (m units) Table 62. North America Sotalol Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Sotalol Sales by Application (2021-2026) & (m units) Table 64. Europe Sotalol Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Sotalol Sales by Application (2021-2026) & (m units) Table 66. Asia-Pacific Sotalol Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Sotalol Sales by Application (2021-2026) & (m units) Table 68. Latin America Sotalol Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Sotalol Sales by Application (2021-2026) & (m units) Table 70. Middle East and Africa Sotalol Sales by Application (2021-2026) & (US$ Million) Table 71. Shaanxi Hanjiang Pharmaceutical Group Company Information Table 72. Shaanxi Hanjiang Pharmaceutical Group Business Overview Table 73. Shaanxi Hanjiang Pharmaceutical Group Sotalol Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 74. Shaanxi Hanjiang Pharmaceutical Group Sotalol Product Portfolio Table 75. Shaanxi Hanjiang Pharmaceutical Group Recent Development Table 76. GSK Company Information Table 77. GSK Business Overview Table 78. GSK Sotalol Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 79. GSK Sotalol Product Portfolio Table 80. GSK Recent Development Table 81. Bayer Company Information Table 82. Bayer Business Overview Table 83. Bayer Sotalol Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 84. Bayer Sotalol Product Portfolio Table 85. Bayer Recent Development Table 86. Samarth Pharma Pvt. Ltd. Company Information Table 87. Samarth Pharma Pvt. Ltd. Business Overview Table 88. Samarth Pharma Pvt. Ltd. Sotalol Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 89. Samarth Pharma Pvt. Ltd. Sotalol Product Portfolio Table 90. Samarth Pharma Pvt. Ltd. Recent Development Table 91. Cipla Limited Company Information Table 92. Cipla Limited Business Overview Table 93. Cipla Limited Sotalol Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 94. Cipla Limited Sotalol Product Portfolio Table 95. Cipla Limited Recent Development Table 96. Cambrex Company Information Table 97. Cambrex Business Overview Table 98. Cambrex Sotalol Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 99. Cambrex Sotalol Product Portfolio Table 100. Cambrex Recent Development Table 101. Bristol-Myers Squibb (BMS) Company Information Table 102. Bristol-Myers Squibb (BMS) Business Overview Table 103. Bristol-Myers Squibb (BMS) Sotalol Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 104. Bristol-Myers Squibb (BMS) Sotalol Product Portfolio Table 105. Bristol-Myers Squibb (BMS) Recent Development Table 106. Arevipharma Company Information Table 107. Arevipharma Business Overview Table 108. Arevipharma Sotalol Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 109. Arevipharma Sotalol Product Portfolio Table 110. Arevipharma Recent Development Table 111. Arbor Pharmaceuticals Company Information Table 112. Arbor Pharmaceuticals Business Overview Table 113. Arbor Pharmaceuticals Sotalol Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 114. Arbor Pharmaceuticals Sotalol Product Portfolio Table 115. Arbor Pharmaceuticals Recent Development Table 116. North America Sotalol Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 117. North America Sotalol Sales by Country (2021-2026) & (m units) Table 118. North America Sotalol Sales Market Share by Country (2021-2026) Table 119. North America Sotalol Sales Forecast by Country (2027-2032) & (m units) Table 120. North America Sotalol Sales Market Share Forecast by Country (2027-2032) Table 121. North America Sotalol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Sotalol Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Sotalol Market Share by Country (2021-2026) Table 124. North America Sotalol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Sotalol Market Share Forecast by Country (2027-2032) Table 126. Europe Sotalol Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 127. Europe Sotalol Sales by Country (2021-2026) & (m units) Table 128. Europe Sotalol Sales Market Share by Country (2021-2026) Table 129. Europe Sotalol Sales Forecast by Country (2027-2032) & (m units) Table 130. Europe Sotalol Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Sotalol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Sotalol Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Sotalol Market Share by Country (2021-2026) Table 134. Europe Sotalol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Sotalol Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Sotalol Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Sotalol Sales by Country (2021-2026) & (m units) Table 138. Asia-Pacific Sotalol Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Sotalol Sales Forecast by Country (2027-2032) & (m units) Table 140. Asia-Pacific Sotalol Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Sotalol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Sotalol Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Sotalol Market Share by Country (2021-2026) Table 144. Asia-Pacific Sotalol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Sotalol Market Share Forecast by Country (2027-2032) Table 146. Latin America Sotalol Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 147. Latin America Sotalol Sales by Country (2021-2026) & (m units) Table 148. Latin America Sotalol Sales Market Share by Country (2021-2026) Table 149. Latin America Sotalol Sales Forecast by Country (2027-2032) & (m units) Table 150. Latin America Sotalol Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Sotalol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Sotalol Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Sotalol Market Share by Country (2021-2026) Table 154. Latin America Sotalol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Sotalol Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Sotalol Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Sotalol Sales by Country (2021-2026) & (m units) Table 158. Middle East and Africa Sotalol Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Sotalol Sales Forecast by Country (2027-2032) & (m units) Table 160. Middle East and Africa Sotalol Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Sotalol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Sotalol Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Sotalol Market Share by Country (2021-2026) Table 164. Middle East and Africa Sotalol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Sotalol Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Sotalol Distributors List Table 169. Sotalol Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Sotalol Image Figure 2. Global Sotalol Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sotalol Market Size (2021-2032) & (US$ Million) Figure 4. Global Sotalol Sales (2021-2032) & (m units) Figure 5. 40mg Sotalol Image Figure 6. Global 40mg Sotalol Sales YoY Growth (2021-2032) & (m units) Figure 7. 80mg Sotalol Image Figure 8. Global 80mg Sotalol Sales YoY Growth (2021-2032) & (m units) Figure 9. Global Sotalol Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Sotalol Market Share by Type 2025 VS 2032 Figure 11. North America Sotalol Sales Market Share in Volume by Type in 2025 Figure 12. North America Sotalol Sales Market Share in Value by Type in 2025 Figure 13. Europe Sotalol Sales Market Share in Volume by Type in 2025 Figure 14. Europe Sotalol Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Sotalol Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Sotalol Sales Market Share in Value by Type in 2025 Figure 17. Latin America Sotalol Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Sotalol Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Sotalol Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Sotalol Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Sotalol Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Sustained Ventricular Tachycardia Image Figure 24. Global Sustained Ventricular Tachycardia Sales YoY Growth (2021-2032) & (m units) Figure 25. Atrial Fibrillation/Flutter Image Figure 26. Global Atrial Fibrillation/Flutter Sales YoY Growth (2021-2032) & (m units) Figure 27. Global Sotalol Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Sotalol Market Share by Application 2025 VS 2032 Figure 29. North America Sotalol Sales Market Share in Volume by Application in 2025 Figure 30. North America Sotalol Sales Market Share in Value by Application in 2025 Figure 31. Europe Sotalol Sales Market Share in Volume by Application in 2025 Figure 32. Europe Sotalol Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Sotalol Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Sotalol Sales Market Share in Value by Application in 2025 Figure 35. Latin America Sotalol Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Sotalol Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Sotalol Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Sotalol Sales Market Share in Value by Application in 2025 Figure 39. North America Sotalol Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 40. North America Sotalol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Sotalol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Sotalol Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Sotalol Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 44. Europe Sotalol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Sotalol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Sotalol Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Sotalol Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 48. Asia-Pacific Sotalol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Sotalol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Sotalol Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Sotalol Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 52. Latin America Sotalol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Sotalol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Sotalol Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Sotalol Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 56. Middle East and Africa Sotalol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Sotalol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Sotalol Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Sotalol Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Sotalol Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 40mg Sotalol
  • 80mg Sotalol
Applications
  • Sustained Ventricular Tachycardia
  • Atrial Fibrillation/Flutter
Companies covered
  • Shaanxi Hanjiang Pharmaceutical Group
  • GSK
  • Bayer
  • Samarth Pharma Pvt. Ltd.
  • Cipla Limited
  • Cambrex
  • Bristol-Myers Squibb (BMS)
  • Arevipharma
  • Arbor Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sotalol Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sotalol Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Sotalol Market by Type
  6. 1.3.1 40mg Sotalol
  7. 1.3.2 80mg Sotalol
  8. 1.4 Global Sotalol Market Size by Type
  9. 1.4.1 Global Sotalol Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Sotalol Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Sotalol Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Sotalol Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Sotalol Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Sotalol Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Sotalol Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Sotalol Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Sotalol Industry Trends
  2. 2.2 Sotalol Industry Drivers
  3. 2.3 Sotalol Industry Opportunities and Challenges
  4. 2.4 Sotalol Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Sotalol Revenue (2021-2026)
  2. 3.2 Global Top Players by Sotalol Sales (2021-2026)
  3. 3.3 Global Top Players by Sotalol Price (2021-2026)
  4. 3.4 Global Sotalol Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sotalol Major Company Production Sites & Headquarters
  6. 3.6 Global Sotalol Company, Product Type & Application
  7. 3.7 Global Sotalol Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sotalol Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sotalol Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sotalol Tier 1, Tier 2, and Tier 3
4 Sotalol Regional Status and Outlook
  1. 4.1 Global Sotalol Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Sotalol Historic Market Size by Region
  3. 4.2.1 Global Sotalol Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Sotalol Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Sotalol Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Sotalol Forecasted Market Size by Region
  7. 4.3.1 Global Sotalol Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Sotalol Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Sotalol Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sotalol by Application
  1. 5.1 Sotalol Market by Application
  2. 5.1.1 Sustained Ventricular Tachycardia
  3. 5.1.2 Atrial Fibrillation/Flutter
  4. 5.2 Global Sotalol Market Size by Application
  5. 5.2.1 Global Sotalol Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Sotalol Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Sotalol Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Sotalol Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Sotalol Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Sotalol Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Sotalol Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Sotalol Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shaanxi Hanjiang Pharmaceutical Group
  2. 6.1.1 Shaanxi Hanjiang Pharmaceutical Group Company Information
  3. 6.1.2 Shaanxi Hanjiang Pharmaceutical Group Business Overview
  4. 6.1.3 Shaanxi Hanjiang Pharmaceutical Group Sotalol Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shaanxi Hanjiang Pharmaceutical Group Sotalol Product Portfolio
  6. 6.1.5 Shaanxi Hanjiang Pharmaceutical Group Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK Sotalol Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK Sotalol Product Portfolio
  12. 6.2.5 GSK Recent Developments
  13. 6.3 Bayer
  14. 6.3.1 Bayer Company Information
  15. 6.3.2 Bayer Business Overview
  16. 6.3.3 Bayer Sotalol Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bayer Sotalol Product Portfolio
  18. 6.3.5 Bayer Recent Developments
  19. 6.4 Samarth Pharma Pvt. Ltd.
  20. 6.4.1 Samarth Pharma Pvt. Ltd. Company Information
  21. 6.4.2 Samarth Pharma Pvt. Ltd. Business Overview
  22. 6.4.3 Samarth Pharma Pvt. Ltd. Sotalol Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Samarth Pharma Pvt. Ltd. Sotalol Product Portfolio
  24. 6.4.5 Samarth Pharma Pvt. Ltd. Recent Developments
  25. 6.5 Cipla Limited
  26. 6.5.1 Cipla Limited Company Information
  27. 6.5.2 Cipla Limited Business Overview
  28. 6.5.3 Cipla Limited Sotalol Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Cipla Limited Sotalol Product Portfolio
  30. 6.5.5 Cipla Limited Recent Developments
  31. 6.6 Cambrex
  32. 6.6.1 Cambrex Company Information
  33. 6.6.2 Cambrex Business Overview
  34. 6.6.3 Cambrex Sotalol Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Cambrex Sotalol Product Portfolio
  36. 6.6.5 Cambrex Recent Developments
  37. 6.7 Bristol-Myers Squibb (BMS)
  38. 6.7.1 Bristol-Myers Squibb (BMS) Company Information
  39. 6.7.2 Bristol-Myers Squibb (BMS) Business Overview
  40. 6.7.3 Bristol-Myers Squibb (BMS) Sotalol Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bristol-Myers Squibb (BMS) Sotalol Product Portfolio
  42. 6.7.5 Bristol-Myers Squibb (BMS) Recent Developments
  43. 6.8 Arevipharma
  44. 6.8.1 Arevipharma Company Information
  45. 6.8.2 Arevipharma Business Overview
  46. 6.8.3 Arevipharma Sotalol Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Arevipharma Sotalol Product Portfolio
  48. 6.8.5 Arevipharma Recent Developments
  49. 6.9 Arbor Pharmaceuticals
  50. 6.9.1 Arbor Pharmaceuticals Company Information
  51. 6.9.2 Arbor Pharmaceuticals Business Overview
  52. 6.9.3 Arbor Pharmaceuticals Sotalol Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Arbor Pharmaceuticals Sotalol Product Portfolio
  54. 6.9.5 Arbor Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Sotalol Sales by Country
  2. 7.1.1 North America Sotalol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Sotalol Sales by Country (2021-2026)
  4. 7.1.3 North America Sotalol Sales Forecast by Country (2027-2032)
  5. 7.2 North America Sotalol Market Size by Country
  6. 7.2.1 North America Sotalol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Sotalol Market Size by Country (2021-2026)
  8. 7.2.3 North America Sotalol Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Sotalol Sales by Country
  2. 8.1.1 Europe Sotalol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Sotalol Sales by Country (2021-2026)
  4. 8.1.3 Europe Sotalol Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Sotalol Market Size by Country
  6. 8.2.1 Europe Sotalol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Sotalol Market Size by Country (2021-2026)
  8. 8.2.3 Europe Sotalol Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Sotalol Sales by Country
  2. 9.1.1 Asia-Pacific Sotalol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Sotalol Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Sotalol Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Sotalol Market Size by Country
  6. 9.2.1 Asia-Pacific Sotalol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Sotalol Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Sotalol Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Sotalol Sales by Country
  2. 10.1.1 South America Sotalol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Sotalol Sales by Country (2021-2026)
  4. 10.1.3 South America Sotalol Sales Forecast by Country (2027-2032)
  5. 10.2 South America Sotalol Market Size by Country
  6. 10.2.1 South America Sotalol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Sotalol Market Size by Country (2021-2026)
  8. 10.2.3 South America Sotalol Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Sotalol Sales by Country
  2. 11.1.1 Middle East and Africa Sotalol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Sotalol Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Sotalol Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Sotalol Market Size by Country
  6. 11.2.1 Middle East and Africa Sotalol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Sotalol Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Sotalol Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Sotalol Value Chain Analysis
  2. 12.1.1 Sotalol Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Sotalol Production Mode & Process
  7. 12.2 Sotalol Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Sotalol Distributors
  10. 12.2.3 Sotalol Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst